AI could protect public health by monitoring water treatment systems

Artificial intelligence (AI) is proving valuable across the healthcare spectrum—from helping radiologists screen for disease to predicting difficulties during surgery. Researchers now hope the cutting-edge technology could safeguard public health by monitoring large-scale water treatment operations.

A team from the University of Waterloo, appropriately enough, in Ontario, Canada, have developed AI capable of monitoring bacteria in water treatment systems. Findings were published online June 13 in Scientific Reports.

"We need to protect our water supplies," said Monica Emelko, a professor of civil and environmental engineering and member of the Water Institute at Waterloo. "This tool will arm us with a sentinel system, a more rapid indication when they are threatened. The exciting piece is that we've shown testing utilizing AI can be done quickly and well. Now, it's time to work through all the possible scenarios and optimize the technology."

The AI software is paired with microscopes to test water samples on an hourly basis. The results are then checked by humans on-site. The researchers believe the AI system could drastically reduce the turnaround time for testing results. Current methods involved sending samples out for laboratory testing or costly automated systems.

"This brings our research into a high-impact area," said Alexander Wong, a systems design engineering professor at Waterloo, who worked on the project. "Helping to ensure safe water through widespread deployment of this technology would be one of the great ways to really make AI count."

""
Nicholas Leider, Managing Editor

Nicholas joined TriMed in 2016 as the managing editor of the Chicago office. After receiving his master’s from Roosevelt University, he worked in various writing/editing roles for magazines ranging in topic from billiards to metallurgy. Currently on Chicago’s north side, Nicholas keeps busy by running, reading and talking to his two cats.

Around the web

With generative AI coming into its own, AI regulators must avoid relying too much on principles of risk management—and not enough on those of uncertainty management.

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Trimed Popup
Trimed Popup